Connect Biopharma Holdings (CNTB) Change in Receivables (2024 - 2026)
Connect Biopharma Holdings (CNTB) posted quarterly Change in Receivables of -$13000.0 for Q1 2026, up 98.34% year-on-year from -$6554.6 in Q1 2025, and down 225.0% on a QoQ basis from -$4000.0 in Q4 2025.
Connect Biopharma Holdings (CNTB) Change in Receivables (2024 - 2026) Analysis & Trends
Connect Biopharma Holdings (CNTB) has reported Change in Receivables for 3 consecutive years, with -$13000.0 the latest figure, recorded in Q1 2026.
- Quarterly Change in Receivables rose 98.34% year-over-year to -$13000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$8000.0 (down 200.0% YoY) and the FY2025 annual result came in at -$776000.0, down 198.35% from the prior year.
- Change in Receivables declined to -$13000.0 in Q1 2026 per CNTB's latest filing, from -$4000.0 in the prior quarter.
- Over the last five years, Change in Receivables for CNTB reached as high as $5.0 million in Q3 2024 and fell as low as -$4.2 million in Q4 2024.
- A 3-year average of $0.0 and a median of -$8000.0 in 2025 frame the typical range for Change in Receivables.
- The largest YoY upside for Change in Receivables was 99.91% in 2025 against a maximum downside of 99.66% in 2025.
- Year by year, Change in Receivables stood at -$4.2 million in 2024, then surged by 99.91% to -$4000.0 in 2025, then slumped by 225.0% to -$13000.0 in 2026.
- According to Business Quant data, Change in Receivables over the past three periods registered -$13000.0, -$4000.0, and $17000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 75.30 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Connect Biopharma Holdings | 120.44 Mn | 120.44 Mn | - | -13,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13,000.00 |
| Mar 31, 2026 | -13,000.00 |
| Dec 31, 2025 | -4,000.00 |
| Dec 31, 2025 | -4,000.00 |
| Sep 30, 2025 | 17,000.00 |
| Sep 30, 2025 | 17,000.00 |
| Jun 30, 2025 | -8,000.00 |
| Jun 30, 2025 | -8,000.00 |
| Mar 31, 2025 | -781,000.00 |
| Mar 31, 2025 | -781,000.00 |
| Dec 31, 2024 | -4.23 Mn |
| Dec 31, 2024 | -4.23 Mn |
| Sep 30, 2024 | 5.02 Mn |
| Sep 30, 2024 | 5.02 Mn |